Local biopharmaceutical firm to conduct phase 3 trial for Enbrel

Biotrion Co., an affiliated biopharmaceutical company of Futureinfonet in Korea, says it has received approval from the Korea Food and Drug Administration to conduct phase 3 clinical trial covering its biosimilar drug of the blockbuster rheumatoid arthritis and psoriasis drug Enbrel the US based Amgen Inc. developed.

Biosimilars are new versions of existing biopharmaceuticals whose patents h...